Plasma TGF-β1 Levels in Type 2 Diabetes Patients with Heart Failure
Author Information
Author(s): Yunjing Sun, Bo Miao, Yabing Cao, Jiangman Cui, Yingxiao Da, Liping Qi, Song Zhou
Primary Institution: Xingtai Third Hospital, Xingtai, China
Hypothesis
The study aims to examine the significance of plasma TGF-β1 level testing in patients with Type 2 Diabetes Mellitus (T2DM) and heart failure.
Conclusion
Plasma TGF-β1 levels were much higher in T2DM patients than in the general population, especially in those with heart failure.
Supporting Evidence
- 96 individuals with T2DM and heart failure showed greater serum and plasma levels of NT-proBNP and TGF-β1 compared to those without heart failure.
- The sensitivity and specificity for diagnosing heart failure in T2DM patients were found to be 79.63% and 52.51%, respectively.
- A strong positive correlation (r=0.784) was found between plasma TGF-β1 and serum NT-proBNP levels.
Takeaway
This study found that people with diabetes and heart failure have higher levels of a specific protein, TGF-β1, which can help doctors diagnose heart problems.
Methodology
The study involved 150 T2DM patients hospitalized for dyspnea and compared their plasma TGF-β1 levels with a control group of 50 healthy individuals.
Limitations
The study did not follow up with patients, making it impossible to verify the prognostic value of TGF-β1 levels.
Participant Demographics
The study group included 99 males and 51 females, aged 41 years and older.
Statistical Information
P-Value
0.05
Confidence Interval
0.734–0.871
Statistical Significance
p=0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website